Professor Mark Cook
As a representative for clinicians, Professor Cook works with CIBF to foster impact, particularly in connection to translating research findings into techniques and devices for the prevention or treatment of neurological conditions.
Mark’s interests include computational models of epilepsy and seizure prediction, and critical excitability. His commercially-focused research is concerned with the development of an implantable device to treat epilepsy and novel polymer-based drug deliver systems.
Mark is involved with a range of community-based activities, including media engagement and community education. He is chairman of the board of the Epilepsy Foundation of Victoria, a large community-based organisation with 30 staff. He participates annually in the Asian Epilepsy Education program, travelling to China, the Philippines, Indonesia and Malaysia.
Professor John Rostas
Professor Rostas represents scientific societies and the broader community of Australian neuroscientists — important end-users of CIBF research. John will foster CIBF’s impact in education and training, as well as encourage translation of CIBF findings into social and commercial outcomes.
Professor Rostas is Past President of the Australasian Neuroscience Society and Emeritus Professor in the Faculty of Health and Medicine, University of Newcastle.
John’s research interests are in molecular mechanisms of synaptic plasticity.
Professor Robert Shepherd
Professor Shepherd represents scientists who develop neural prostheses for treatment of diseases.
Professor Shepherd is Director of Bionics Institute.
Rob has worked for 30 years in the commercial and scientific development of safe and effective cochlear implants, devices that have been implanted in 220 000 deaf adults and children worldwide. More recently, he has expanded his multidisciplinary research to contribute to development of a bionic eye, leading the preclinical program for Bionic Vision Australia.
At the Bionics Institute, he has overseen the expansion of its research portfolio to include a neurobionic platform technology to alleviate a range of central nervous system disorders, such as epilepsy and Parkinson’s disease.
Dr Krystal Evans
Dr Evans serves as a critical link between CIBF research and the Australian biotechnology industry.
Krystal is CEO of BioMelbourne Network, the peak industry forum for leaders of the Victorian biotechnology industry.
Prior to leading the BioMelbourne Network, Dr Evans was a medical research scientist at the Walter and Eliza Hall Institute, Melbourne, where she was developing new malaria vaccines.
Krystal is a passionate science supporter and can be heard on Melbourne community radio station 3RRRFM’s weekly science show “Einstein A Go Go” on Sunday mornings.
Dr Buzz Palmer
Dr Palmer represents the biomedical device industry, and is ideally positioned to help CIBF foster technology commercialisation and overcome barriers to adoption of technologies by industry.
Buzz is CEO of the Small Technologies Cluster. STC has a history of incubating and assisting potential high-growth companies in the advanced manufacturing sector. It has strong ties with academia, industry, government, investor and end-users stakeholders, both within Australia and globally.
Dr Palmer has a record delivering innovative medical technologies and clinical products through the translational pipeline, to advanced manufacturing and export.
Mr Dwayne Cranfield
Mr Cranfield connects CIBF with people from non-English speaking backgrounds with disability, as well as their families and carers.
Dwayne is CEO of the National Ethnic Disability Alliance, a community-based, non-government organisation funded by the Commonwealth Department of Families, Housing, Community Services and Indigenous Affairs.
Mr Suresh Rajan
Mr Rajan connects CIBF wth Australians living with epilepsy.
Suresh is Director of Epilepsy Australia, and CEO of the Epilepsy Association of Western Australia Inc. These associations advocate on behalf of the 1 to 2 percent of the Australian population with epilepsy.
Mr William Robertson
Mr Robinson consults with CIBF investigators about ways to align their research programs with the needs of people with ear and hearing disorders.
William is CEO of Ear Science Institute Australia Inc, and is interested in the impact of brain research on the design of more effective prosthetic devices for people with hearing impairment, in particular central auditory processing disorders.
- Director and chief investigators
- Partner investigators
- Associate investigators
- Contact Brain Function CoE
- Advisory board
- Fellows and scholars
- The Brain Dialogue
- Management team
- Brain Function CoE mission
- End-user representatives
- Neuroinformatics and computational resources
- Gender equity
- Education and training
- Annual reports
- Privacy statement